crypto coin names, Featured snippets

Shangwei Co., Ltd.: Received the Supervision Letter jointly submitted by independent directors. Shangwei Co., Ltd. announced on the evening of December 11 that the company received the Supervision Letter jointly submitted by independent directors on the same day. The independent directors of the company attached great importance to the recovery progress of the occupied funds and the standardized operation of the company.It is reported that the Bank of Japan thinks that it is no harm to raise interest rates later, but it does not rule out taking action in December. On December 11th, according to informed sources, officials of the Bank of Japan believe that it is not costly to raise interest rates later, and they are still open to taking action next week, depending on data and market trends. The authorities believe that even if the Bank of Japan decides to wait until January or later, it will not pay a huge price, because there are signs that there is little risk that inflation may exceed the target. They also said that if the December meeting proposed to raise interest rates, some officials would not object. According to people familiar with the matter, officials think it is only a matter of time to raise interest rates again, because the economy and inflation are in line with their forecasts. Before announcing the policy decision on December 19, officials will carefully evaluate the data and financial markets before making a final decision.Song Zhexie, Samsung Semiconductor: I feel the great potential of the semiconductor market in China and I am very willing to grow with China customers. At the Shanghai IC Industry Development Forum 2024 held today, Song Zhe Xie, general manager of Samsung Semiconductor Foundry Greater China, said that the semiconductor industry in China is not only growing in scale, but also improving the development quality of the whole industry from the product upgrading and process evolution of Samsung semiconductor customers. The development of new quality productivity is helping the semiconductor market in China to flourish. In the cooperation with customers in China, I feel the great potential of the semiconductor market in China, and I am very willing to grow with customers in China, and provide diversified solutions to meet the needs of customers in China to enhance the competitiveness of products.

OPEC Monthly Report: Russia slightly cut its oil production in November. On Wednesday, OPEC quoted data from second-hand sources as saying that Russia's crude oil production in November decreased slightly by 0.7 million barrels per day to about 8.99 million barrels per day. This is basically consistent with Russia's monthly production quota of 8.98 million barrels under the OPEC+agreement (including voluntary production reduction). Russia promised to cut production in October and November this year and from March to September next year to make up for the excess production since April. The output of Iraq and Kazakhstan has also been higher than the target, and they also promised to further reduce production to compensate for their excess production.*ST Zhongli: The company's reorganization plan was approved by the court. *ST Zhongli announced that the company's reorganization plan had been approved by the Suzhou Intermediate People's Court and the reorganization procedure was terminated. The content of the reorganization plan is consistent with the previously disclosed draft, aiming at comprehensively solving the historical problems of the company's 1.805 billion yuan capital occupation and illegal guarantee. In the implementation stage of the reorganization plan, the company will be responsible for implementation and the manager will be responsible for supervision. If it is successfully implemented, it will help to optimize the company's asset-liability structure, enhance its sustainable operation and profitability, and have a significant impact on the relevant financial indicators in 2024.Pakistan KSE-100 index rose 0.5% to 109,693.20.

Huayuan Real Estate: It is planned to transfer the assets and liabilities related to real estate development business to Huayuan Group, the controlling shareholder of the company. Huayuan Real Estate announced the change, and the company is planning major asset sales and related transactions. It is planned to transfer the assets and liabilities related to real estate development business to Huayuan Group, the controlling shareholder of the company, that is, the company plans to transfer 100% equity of Huayuan Real Estate. As of the evaluation benchmark date (April 30, 2024), the company's receivables from Huayuan Real Estate and its subsidiaries are as follows.R&F Properties announced on the Hong Kong Stock Exchange that the High Court ordered that the hearing of R&F Hong Kong's petition be postponed until December 16, 2024.The Shanghai Stock Exchange approved the refinancing of Dizhe Medicine to support the development of new quality productivity. The announcement of Dizhe Medicine shows that the private placement plan of Dizhe Medicine in science and technology innovation board has been approved by the Shanghai Stock Exchange. This is the first time that the refinancing of unprofitable enterprises in Shanghai Stock Exchange has been approved since the issuance of the Eight Measures on Deepening science and technology innovation board's Reform, Service, Scientific and Technological Innovation and Development of New Productivity by CSRC. As a listed company with the fifth standard in science and technology innovation board, Dizhe Medicine's refinancing has been approved by Shanghai Stock Exchange, which reflects the institutional inclusiveness and support of the capital market for supporting new quality productivity and unprofitable technology-based enterprises with key core technologies, great market potential and outstanding scientific and technological attributes. Dizhe Medicine said that the company's refinancing will help the company to further accelerate product research and development and production base construction, create new quality productivity, implement major national strategies, promote products to the sea, and give scientific and technological impetus to the development of biomedical economy. (Sina Technology)